Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
08/2006
08/30/2006CN1826322A Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related therto
08/30/2006CN1826319A Aryl-heteroaromatic compounds, compositions comprising them and use
08/30/2006CN1272324C Novel herbicides
08/29/2006US7098201 Heteroaromatic derivatives having an inhibitory activity against HIV integrase
08/29/2006CA2112779C Arylsulfonamido-substituted hydroxamic acids
08/24/2006WO2006087732A1 An amorphous and three crystalline forms of rimonabant hydrochloride
08/24/2006WO2006087480A1 (1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics
08/24/2006WO2006087343A1 Pyrazole carboxylic acid anilides, method for the production thereof and agents containing them for controlling pathogenic fungi
08/24/2006WO2006066126A3 Phenol-heterocyclic ligands, metal complexes, and their uses as catalysts
08/24/2006WO2005004810A3 Arylsulfonamide derivatives
08/24/2006US20060189810 Novel sulfonamide inhibitors of aspartyl protease
08/24/2006US20060189666 Alzheimer's disease; bridged bicycloalkyl sulphonamide and sulphamide derivatives; [9-endo]2',3', 4',5'-Tetrahydro-5'-(2.2.2-trifluoroethyl)spiro[3-{(E)-2-[5-(4-fluorophenyl)-1-methyl-1H-pyrazol-3-yl]ethenyl}-4-methyl bicyclo[4.2.1]non-3-ene]-9,3'-[1,2,5]thiadiazol-1',1'-dioxide
08/24/2006US20060189658 Substituted pyrazoline compounds, their preparation and use as medicaments
08/24/2006US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
08/24/2006US20060189549 Chalcone derivatives and their use to treat diseases
08/24/2006DE19639859B4 1-Arylpyrazole, Zusammensetzungen, besonders giftige Köder zur Schädlingsbekämpfung 1 arylpyrazoles compositions, particularly toxic bait for pest control
08/24/2006DE102005007160A1 Pyrazolcarbonsäureanilide, Verfahren zu ihrer Herstellung und sie enthaltende Mittel zur Bekämpfung von Schadpilzen Pyrazolcarbonsäureanilide, processes for their preparation and compositions containing them for controlling harmful fungi
08/24/2006CA2597359A1 (1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics
08/24/2006CA2597022A1 Pyrazole carboxylic acid anilides, method for the production thereof and agents containing them for controlling pathogenic fungi
08/23/2006EP1693369A1 Protein modifier production inhibitor
08/23/2006EP1692124A1 Biaryl sulfonamides as mmp inhibitors
08/23/2006EP1691810A1 Substituted piperazines
08/23/2006CN1271058C Pyrazoline derivatives and their use as pesticides
08/22/2006US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists
08/22/2006US7094909 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group
08/22/2006US7094906 Processes for preparing pesticidal intermediates
08/22/2006US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis
08/22/2006US7094512 Negative charged toner mixture containing charge controlling compound, coloring agents and binder
08/22/2006CA2257825C New processes for preparing pesticidal intermediates
08/17/2006WO2006086705A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
08/17/2006WO2006086374A2 3-amino-2-aminomethylphenol derivatives and colorants comprising these compounds
08/17/2006WO2006085685A1 Pyrazole compound
08/17/2006WO2006055734A3 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
08/17/2006WO2006037982A3 Modulators of crth2 receptor activity for the treatment of prostaglandin d2 mediated diseases
08/17/2006WO2006021213A3 Vasopressin v1a antagonists
08/17/2006WO2006012513A3 High stability diionic liquid salts
08/17/2006WO2005107762A3 Certain chemical entities, compositions, and methods
08/17/2006US20060183948 Process for producing tetraalkoxypropane and derivative thereof
08/17/2006US20060183785 For the treatment of pain; epilepsy, manic depression, bipolar disorder, depression, anxiety and diabetic neuropathy; 5-Methyl-1-[2'-(trifluoromethoxy)-1,1'-biphenyl-3-yl]-1H-pyrazole-3-carboxamide
08/17/2006US20060183742 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses
08/17/2006CA2598429A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
08/16/2006EP1690854A1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
08/16/2006EP1690852A1 Novel target protein of anticancer agent and novel anticancer agent (spnal) corresponding thereto
08/16/2006EP1689721A1 Aminopyrazole derivatives as gsk-3 inhibitors
08/16/2006EP1689720A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
08/16/2006EP1689406A2 Heterocyclic inhibitors of mek and methods of use thereof
08/16/2006EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof
08/16/2006EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof
08/16/2006EP1087941B1 Thiolesters and uses thereof
08/16/2006EP1028729B1 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds
08/16/2006CN1817867A Aryl pyrazole inulin acidamide compound and use thereof
08/15/2006US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation
08/15/2006US7091350 Produce powerful, particularly chromatic and bright colorations, in red tones, and which are relatively unselective and are stable to outside factors
08/15/2006US7091340 Thermodynamically stable
08/15/2006US7091223 Autoimmune diseases; anticancer agents
08/15/2006US7091198 2,5-disubstituted pyrimidine derivatives
08/15/2006CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity
08/10/2006WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/10/2006WO2006082975A1 Optically active tetrahydronaphthalene derivative
08/10/2006WO2006082952A1 Amide compound
08/10/2006WO2006082001A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
08/10/2006WO2006017055A3 Pyrazole amide derivatives, compositions containing such compounds and methods of use
08/10/2006US20060178523 Process for producing acrylonitrile compound
08/10/2006US20060178518 3'-[(2z)-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hy-drazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
08/10/2006US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease
08/10/2006US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents
08/10/2006CA2596993A1 Optically active tetrahydronaphthalene derivative
08/10/2006CA2596636A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
08/10/2006CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/09/2006EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
08/09/2006EP1687293A1 Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)
08/09/2006EP1687285A1 Thiazole and pyrazole derivatives as flt-3 kinase inhibitors
08/09/2006EP1687280A1 Cationic diaminopyrazoles, a method for the production thereof and dyes containing these compounds
08/09/2006EP1483245B1 5-substituted-alkylaminopyrazole derivatives as pesticides
08/09/2006EP1453832B1 Ring fused pyrazole derivatives
08/09/2006EP1315491B1 Use of substituted pyrazoles for the manufacture of a medicament for the treatment of allergies
08/09/2006CN1816532A Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents
08/09/2006CN1816529A Pyrazole-amide compounds useful as kinase inhibitors
08/09/2006CN1268614C Substituted pyrazolyl benzsulfamide compound for curing inflammation
08/08/2006US7087786 phenylpyrazole compounds or 5-amino-1-aryl-3-cyanopyrazole; high yield and high purity; eliminates the diazotization step and hence avoids hazards known to occur for such reactions
08/08/2006US7087765 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
08/08/2006US7087636 A 4,7-methano-1,2-benzisothiazol-3-one-1,1-dioxide derivatives, for treating cancer, immune modulation
08/08/2006US7087634 Cyclic AMP-specific phosphodiesterase inhibitors
08/08/2006US7087630 Cyclooxygenase 2 selective inhibitors, compositions and methods of use
08/08/2006US7087604 Antiarthritic agents;multiple sclerosis; anticholesterol agents; cardiovascular disorders
08/08/2006US7087598 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring
08/03/2006WO2006081335A2 Process for preparing substituted 1- [3- ( pyrazolyl) phenyl] -3-phenyl ureas
08/03/2006WO2006080450A1 Igf-1r inhibitor
08/03/2006WO2006080406A1 Tricyclic compounds
08/03/2006WO2006080311A1 Anthranilamide compound, method for producing same and pest control agent containing same
08/03/2006WO2006079923A2 Form iv crystalline celecoxib
08/03/2006WO2006061638A3 Heterocycle derivatives as histone deacetylase (hdac) inhibitors
08/03/2006WO2005084392A3 4-methylpyrazole formulations for inhibiting ethanol intolerance
08/03/2006CA2596527A1 Igf-1r inhibitors
08/03/2006CA2595675A1 Form iv crystalline celecoxib
08/03/2006CA2594915A1 Phenyl-substituted pyrrolidones
08/03/2006CA2592116A1 Anti-inflammatory medicaments
08/03/2006CA2591445A1 Process for preparing substituted 1- [3- ( pyrazolyl) phenyl] -3-phenyl ureas
08/02/2006EP1685837A1 Percutaneous absorption type cerebral protective agent
08/02/2006EP1685113A1 Substituted pyrazoles as ppar agonists